StockData
Crescent Biopharma, Inc. logo

Crescent Biopharma, Inc. (CBIO) stock

CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$12.40−0.64 (-4.91%)

Close on Nov 18, 2026Market cap $460.59MP/E –Yield –

Crescent Biopharma gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Crescent Biopharma

Crescent Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Crescent Biopharma figures

See a number that looks wrong?